fda glp-1 warning news september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes Beyond the Headlines: FDA Warning

J.MirandaM.RomeroF

Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital

Pick the right molecule, and everything from energy to skin to lifespan falls into place

Both compounds are subcutaneous once-weekly

At Perfect B, GHK-Cu is delivered through 2 primary methods: topical application combined with microneedling for direct scalp delivery, or scalp injection for higher-dose protocols

At the same time, breakthrough therapies and emerging fields like longevity medicine are redefining what effective care looks like, creating new considerations for how employers design benefits and plan for future costs